Objective
To investigate the nationwide prevalence and incidence of serious infections among children with systemic lupus erythematosus (SLE) enrolled in Medicaid, the U.S. health insurance program for low-income patients.
Methods
From Medicaid claims (2000–2006) we identified children 5 to <18 years old with SLE (≥3 ICD-9 codes of 710.0, each >30 days apart) and lupus nephritis (LN; ≥2 ICD-9 codes for kidney disease on/after SLE codes). From hospital discharge diagnoses, we identified infection subtypes (bacterial, fungal, viral). We calculated incidence rates (IR) per 100 person-years (PY), mortality rates, and hazard ratios adjusted for sociodemographic factors, medications, and preventive care.
Results
Among 3,500 children with SLE identified, 1,053 serious infections occurred over 10,108 person-years; the IR was 10.42/100 PY (95% CI 9.80, 11.07) among all those with SLE and 17.65/100 PY (95% CI 16.29, 19.09) among those with LN. Bacterial infections were most common (87%; of which 39% were bacterial pneumonias). In adjusted models, African Americans and Native Americans had higher rates of infections compared with white children, and those with comorbidities or receiving corticosteroids had higher infection rates than those without. Males had lower rates of serious infections compared to females. The 30-day post-discharge mortality rate was 4.4%.
Conclusions
Overall, hospitalized infections were very common in children with SLE, with bacterial pneumonia being the most common infection. Highest infection risks were among African and Native American children, those with LN, comorbidities, and those taking corticosteroids.